Id |
Subject |
Object |
Predicate |
Lexical cue |
T24 |
0-1 |
IN |
denotes |
• |
T25 |
3-7 |
NNP |
denotes |
IVIG |
T26 |
7-8 |
-COMMA- |
denotes |
, |
T27 |
9-17 |
VBN |
denotes |
combined |
T28 |
18-22 |
IN |
denotes |
with |
T29 |
23-36 |
NN |
denotes |
moderate-dose |
T30 |
37-39 |
IN |
denotes |
of |
T31 |
40-55 |
NNS |
denotes |
corticosteroids |
T32 |
55-56 |
-COMMA- |
denotes |
, |
T33 |
57-62 |
MD |
denotes |
might |
T34 |
63-70 |
VB |
denotes |
improve |
T35 |
71-78 |
NN |
denotes |
patient |
T36 |
79-87 |
NNS |
denotes |
outcomes |
T37 |
89-90 |
PDT |
denotes |
• |
T38 |
92-95 |
DT |
denotes |
The |
T39 |
96-99 |
NN |
denotes |
use |
T40 |
100-102 |
IN |
denotes |
of |
T41 |
103-118 |
NNS |
denotes |
corticosteroids |
T42 |
119-124 |
MD |
denotes |
might |
T43 |
125-135 |
VB |
denotes |
accelerate |
T44 |
136-144 |
NN |
denotes |
recovery |
T45 |
145-149 |
IN |
denotes |
from |
T46 |
150-158 |
NN |
denotes |
COVID-19 |
T47 |
160-161 |
PDT |
denotes |
• |
T48 |
163-165 |
DT |
denotes |
No |
T49 |
166-176 |
VBN |
denotes |
controlled |
T50 |
177-185 |
JJ |
denotes |
clinical |
T51 |
186-192 |
NNS |
denotes |
trials |
T52 |
193-198 |
VBP |
denotes |
exist |
T53 |
199-201 |
IN |
denotes |
on |
T54 |
202-205 |
DT |
denotes |
the |
T55 |
206-209 |
NN |
denotes |
use |
T56 |
210-212 |
IN |
denotes |
of |
T57 |
213-228 |
NNS |
denotes |
corticosteroids |
T58 |
229-232 |
IN |
denotes |
for |
T59 |
233-241 |
NN |
denotes |
COVID-19 |
T60 |
243-244 |
LS |
denotes |
• |
T61 |
246-249 |
NN |
denotes |
IL6 |
T62 |
250-260 |
VBZ |
denotes |
correlates |
T63 |
261-265 |
IN |
denotes |
with |
T64 |
266-274 |
NN |
denotes |
severity |
T65 |
274-275 |
-COMMA- |
denotes |
, |
T66 |
276-287 |
NN |
denotes |
criticality |
T67 |
287-288 |
-COMMA- |
denotes |
, |
T68 |
289-294 |
JJ |
denotes |
viral |
T69 |
295-299 |
NN |
denotes |
load |
T70 |
299-300 |
-COMMA- |
denotes |
, |
T71 |
301-304 |
CC |
denotes |
and |
T72 |
305-314 |
NN |
denotes |
prognosis |
T73 |
315-317 |
IN |
denotes |
of |
T74 |
318-326 |
NN |
denotes |
COVID-19 |
T75 |
328-329 |
IN |
denotes |
• |
T76 |
331-342 |
NNP |
denotes |
Tocilizumab |
T77 |
342-343 |
-COMMA- |
denotes |
, |
T78 |
344-346 |
DT |
denotes |
an |
T79 |
347-355 |
NN |
denotes |
anti-IL6 |
T80 |
355-356 |
-COMMA- |
denotes |
, |
T81 |
357-360 |
MD |
denotes |
can |
T82 |
361-367 |
VB |
denotes |
confer |
T83 |
368-375 |
NN |
denotes |
benefit |
T84 |
376-378 |
IN |
denotes |
in |
T85 |
379-387 |
NNS |
denotes |
patients |
T86 |
388-392 |
IN |
denotes |
with |
T87 |
393-401 |
NN |
denotes |
COVID-19 |
T88 |
402-405 |
CC |
denotes |
and |
T89 |
406-410 |
JJ |
denotes |
high |
T90 |
411-414 |
NN |
denotes |
IL6 |
R20 |
T25 |
T24 |
arg1Of |
IVIG,• |
R21 |
T25 |
T26 |
arg1Of |
IVIG,"," |
R22 |
T25 |
T27 |
arg2Of |
IVIG,combined |
R23 |
T27 |
T28 |
arg1Of |
combined,with |
R24 |
T29 |
T28 |
arg2Of |
moderate-dose,with |
R25 |
T29 |
T30 |
arg1Of |
moderate-dose,of |
R26 |
T31 |
T30 |
arg2Of |
corticosteroids,of |
R27 |
T34 |
T32 |
arg1Of |
improve,"," |
R28 |
T25 |
T33 |
arg1Of |
IVIG,might |
R29 |
T34 |
T33 |
arg2Of |
improve,might |
R30 |
T25 |
T34 |
arg1Of |
IVIG,improve |
R31 |
T36 |
T34 |
arg2Of |
outcomes,improve |
R32 |
T36 |
T35 |
arg1Of |
outcomes,patient |
R33 |
T39 |
T37 |
arg1Of |
use,• |
R34 |
T39 |
T38 |
arg1Of |
use,The |
R35 |
T39 |
T40 |
arg1Of |
use,of |
R36 |
T41 |
T40 |
arg2Of |
corticosteroids,of |
R37 |
T39 |
T42 |
arg1Of |
use,might |
R38 |
T43 |
T42 |
arg2Of |
accelerate,might |
R39 |
T39 |
T43 |
arg1Of |
use,accelerate |
R40 |
T44 |
T43 |
arg2Of |
recovery,accelerate |
R41 |
T44 |
T45 |
arg1Of |
recovery,from |
R42 |
T46 |
T45 |
arg2Of |
COVID-19,from |
R43 |
T51 |
T47 |
arg1Of |
trials,• |
R44 |
T51 |
T48 |
arg1Of |
trials,No |
R45 |
T51 |
T49 |
arg2Of |
trials,controlled |
R46 |
T51 |
T50 |
arg1Of |
trials,clinical |
R47 |
T51 |
T52 |
arg1Of |
trials,exist |
R48 |
T52 |
T53 |
arg1Of |
exist,on |
R49 |
T55 |
T53 |
arg2Of |
use,on |
R50 |
T55 |
T54 |
arg1Of |
use,the |
R51 |
T55 |
T56 |
arg1Of |
use,of |
R52 |
T57 |
T56 |
arg2Of |
corticosteroids,of |
R53 |
T55 |
T58 |
arg1Of |
use,for |
R54 |
T59 |
T58 |
arg2Of |
COVID-19,for |
R55 |
T62 |
T60 |
arg1Of |
correlates,• |
R56 |
T61 |
T62 |
arg1Of |
IL6,correlates |
R57 |
T62 |
T63 |
arg1Of |
correlates,with |
R58 |
T71 |
T63 |
arg2Of |
and,with |
R59 |
T64 |
T65 |
arg1Of |
severity,"," |
R60 |
T66 |
T65 |
arg2Of |
criticality,"," |
R61 |
T65 |
T67 |
arg1Of |
",","," |
R62 |
T69 |
T67 |
arg2Of |
load,"," |
R63 |
T69 |
T68 |
arg1Of |
load,viral |
R64 |
T71 |
T70 |
arg1Of |
and,"," |
R65 |
T67 |
T71 |
arg1Of |
",",and |
R66 |
T72 |
T71 |
arg2Of |
prognosis,and |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |